Evidence map›Paper›PMID 24510126›Full record

ArticleCell death and differentiation2014

IL-15 maintains T-cell survival via S-nitrosylation-mediated inhibition of caspase-3.

P T Saligrama, K A Fortner, M A Secinaro, C C Collins, J Q Russell, R C Budd

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. A Human Tumor-Immune Organoid Model of Glioblastoma.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Immune network · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

P T SaligramaVermont Center for Immunology and Infectious Diseases, University of Vermont College of Medicine, Burlington, VT, USA.
K A FortnerVermont Center for Immunology and Infectious Diseases, University of Vermont College of Medicine, Burlington, VT, USA.
M A SecinaroVermont Center for Immunology and Infectious Diseases, University of Vermont College of Medicine, Burlington, VT, USA.
C C CollinsVermont Center for Immunology and Infectious Diseases, University of Vermont College of Medicine, Burlington, VT, USA.
J Q RussellVermont Center for Immunology and Infectious Diseases, University of Vermont College of Medicine, Burlington, VT, USA.
R C BuddVermont Center for Immunology and Infectious Diseases, University of Vermont College of Medicine, Burlington, VT, USA.
University of Vermont · US

Funding

Synovial V delta 1 cells kill Th2 cellsP01AI045666 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BUDD, RALPH C · 1999 to 2010
$12.5M
Vermont Immunobioloigy/ Infectious Diseases CenterP20GM103496 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2012 to 2015
$8.7M
GAMMA DELTA T CELLS IN LYME ARTHRITISR01AR043520 · NIAMS · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BUDD, RALPH C · 1994 to 2011
$3.8M
FAS REGULATES T CELL DEVELOPMENT/FUNCTION IN LPR MICER01AI036333 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BUDD, RALPH C · 1996 to 2010
$3.7M
Vermont Immunology/Infectious Diseases Training GrantT32AI055402 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GARY E WARD · 2005 to 2026
$2.7M
NIAID NIH HHS AI036333NIAID NIH HHS AI045666NIAID NIH HHS AI055402NIAID NIH HHS P01 AI045666NIAID NIH HHS R01 AI036333NIAID NIH HHS T32 AI055402NIAMS NIH HHS AR043520NIAMS NIH HHS R01 AR043520NIGMS NIH HHS P20 GM103496
6 · The paper itself

Abstract

Caspase activity is critical for both T-cell survival and death. However, little is known regarding what determines caspase activity in cycling T cells. Interleukin (IL)-2 and IL-15 confer very different susceptibilities to T-cell death. We therefore considered that IL-2 and IL-15 differentially regulate caspase activity to influence T-cell survival. We observed that IL-2-cultured primary murine effector T cells manifested elevated levels of caspase-3 activity compared with IL-15-cultured T cells. T cell receptor (TCR) restimulation further increased caspase activity and induced considerable cell death in IL-2-cultured T cells, but provoked only a minimal increase of caspase activity and cell death in IL-15-cultured T cells. IL-2 sensitization to cell death was caspase-3 mediated. Interestingly, increased active caspase-3 levels with IL-2 were independent of active initiator caspase-8 and caspase-9 that were similar with IL-2 and IL-15. Rather, caspase-3 activity was inhibited by posttranslational S-nitrosylation in IL-15-cultured T cells, but not in the presence of IL-2. This paralleled increased reactive nitrogen and oxygen species with IL-15 and reduced glycolysis. Taken together, these data suggest that the metabolic state conferred by IL-15 inhibits T-cell apoptosis in part by maintaining low levels of active caspase-3 via S-nitrosylation.

Indexed as

AnimalsApoptosisCaspase 3Cell SurvivalGlycolysisInterleukin-15Interleukin-2Lymphocyte ActivationMiceMitochondriaSignal TransductionT-LymphocytesCaspase 3Interleukin-15Interleukin-2

Identifiers

PMID24510126
PMCPMC4013509
OpenAlexW1975056471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.